BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bourn JR, Ruiz-Torres SJ, Hunt BG, Benight NM, Waltz SE. Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Lett 2021;503:75-90. [PMID: 33508385 DOI: 10.1016/j.canlet.2021.01.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Hunt BG, Jones A, Lester C, Davis JC, Benight NM, Waltz SE. RON (MST1R) and HGFL (MST1) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk. Cancers 2022;14:2493. [DOI: 10.3390/cancers14102493] [Reference Citation Analysis]
2 Li M, Li S, Li Y, Li X, Yang G, Li M, Xie Y, Su W, Wu J, Jia L, Li S, Ma W, Li H, Guo N, Yu P. Cationic liposomes co-deliver chemotherapeutics and siRNA for the treatment of breast cancer. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yu Q, Wang J, Li T, Xu X, Guo X, Ding S, Zhu L, Zou G, Chen Y, Zhang X. RON Mediates Tumor-Promoting Effects in Endometrial Adenocarcinoma. Biomed Res Int 2021;2021:2282916. [PMID: 34712728 DOI: 10.1155/2021/2282916] [Reference Citation Analysis]
4 Ou H, Chen K, Wu H. MicroRNA Expression Profiling of Lung Cancer with Differential Expression of the RON Receptor Tyrosine Kinase. J Oncol 2021;2021:5670675. [PMID: 34603447 DOI: 10.1155/2021/5670675] [Reference Citation Analysis]